Advanced

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

Levin Tykjaer Jörgensen, Charlotte LU ; Ejlertsen, Bent; Bjerre, Karsten D.; Balslev, Eva; Nielsen, Dorte Lisbet and Nielsen, Kirsten V (2013) In BMC Cancer 13.
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
in
BMC Cancer
volume
13
publisher
BioMed Central
external identifiers
  • scopus:84887274342
ISSN
1471-2407
DOI
10.1186/1471-2407-13-541
language
English
LU publication?
no
id
079db51c-52f5-47ea-a32d-4d8d5237f249
date added to LUP
2017-04-18 14:37:21
date last changed
2018-05-29 11:45:27
@article{079db51c-52f5-47ea-a32d-4d8d5237f249,
  articleno    = {541},
  author       = {Levin Tykjaer Jörgensen, Charlotte and Ejlertsen, Bent and Bjerre, Karsten D. and Balslev, Eva and Nielsen, Dorte Lisbet and Nielsen, Kirsten V},
  issn         = {1471-2407},
  language     = {eng},
  publisher    = {BioMed Central},
  series       = {BMC Cancer},
  title        = {Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine},
  url          = {http://dx.doi.org/10.1186/1471-2407-13-541},
  volume       = {13},
  year         = {2013},
}